---
figid: PMC3856862__nihms493240f10
figtitle: Therapeutic Strategies to Increase Human Beta-Cell Growth and Proliferation
  by Regulating mTOR and GSK-3/Beta-Catenin Pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3856862
filename: nihms493240f10.jpg
figlink: /pmc/articles/PMC3856862/figure/F10/
number: F10
caption: '(A) Human β-cell insulin resistance in vitro: Nutrient metabolism inhibits
  AMPK and TSC1/2, thus increasing mTOR and S6K1 activities. mTOR/S6K1 overactivation
  results in negative feedback and IRS1/2 degradation, blocking insulin signaling
  and the ability of Akt to inhibit GSK-3 and engage the Wnt signaling pathway. Under
  these insulin resistant conditions, GSK-3 remains active and β-catenin is not translocated
  to the nucleus. (B) Inhibition of GSK-3 by 1-Akp or LiCl results in activation of
  Wnt signaling and β-catenin nuclear translocation in vitro: LiCl or 1-Akp directly
  inhibits GSK-3, thus circumventing insulin resistance as described above, resulting
  in mTOR-dependent β-catenin nuclear translocation. This strategy restores the regenerative
  processes of DNA synthesis, cell cycle progression and proliferation. Dotted lines
  indicate reduced signaling levels.'
papertitle: Therapeutic Strategies to Increase Human β-Cell Growth and Proliferation
  by Regulating mTOR and GSK-3/β-Catenin Pathways.
reftext: Nidhi Rohatgi, et al. Open Endocrinol J. ;4:10.2174/1874216501004010040.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9548516
figid_alias: PMC3856862__F10
figtype: Figure
redirect_from: /figures/PMC3856862__F10
ndex: e6a429cc-deb0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3856862__nihms493240f10.html
  '@type': Dataset
  description: '(A) Human β-cell insulin resistance in vitro: Nutrient metabolism
    inhibits AMPK and TSC1/2, thus increasing mTOR and S6K1 activities. mTOR/S6K1
    overactivation results in negative feedback and IRS1/2 degradation, blocking insulin
    signaling and the ability of Akt to inhibit GSK-3 and engage the Wnt signaling
    pathway. Under these insulin resistant conditions, GSK-3 remains active and β-catenin
    is not translocated to the nucleus. (B) Inhibition of GSK-3 by 1-Akp or LiCl results
    in activation of Wnt signaling and β-catenin nuclear translocation in vitro: LiCl
    or 1-Akp directly inhibits GSK-3, thus circumventing insulin resistance as described
    above, resulting in mTOR-dependent β-catenin nuclear translocation. This strategy
    restores the regenerative processes of DNA synthesis, cell cycle progression and
    proliferation. Dotted lines indicate reduced signaling levels.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GSK3A
  - GSK3B
  - IGF1
  - NISCH
  - IRS1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AKT1
  - AKT2
  - AKT3
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - CTNNB1
  - MTOR
  - EIF4EBP1
  - RPS6KB1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - MYC
  - Cancer
---
